PharmaVoice

JUNE 23, 2022

The company’s CEO explains how its Prix Galien award-winning app bridges patient care, treatment support and clinical research.

Patient Care 326

Patient Care 326

Pharmacy Times

JUNE 23, 2022

The Opioid and Naloxone program at North Dakota State University School of Pharmacy aims to make a difference.

171

171

pharmaphorum

JUNE 23, 2022

Eisai’s digital tool to allow self-assessment of cognitive performance – NouKNOW – will be used in a Japanese project aimed at improving the management of dementia. The smartphone app – which uses a cognition-checking algorithm developed by Australian digital health company Cogstate – will be deployed in Bunkyo City, Tokyo in a dementia monitoring programme.

137

137

Pharmacy Times

JUNE 23, 2022

Insurers are refusing to cover new, highly effective anti-obesity drugs, but some prescribers are getting around the issue.

Insurance 164

Insurance 164

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

JUNE 23, 2022

Even execs get the blues — and when they’re ready for a fresh start, Leslie Loveless, CEO of Slone Partners, says these dos and don’ts could make or break their next job move.

130

130

Pharmacy Times

JUNE 23, 2022

But investigators find that individuals who had shingles that spread to the central nervous system had nearly twice the risk of developing mental deterioration, though it is rare.

139

139

Pharmacy Times

JUNE 23, 2022

Treatment identifies patients with ROS1 fusion-positive non-small cell lung cancer or those with NTRK fusion-positive solid tumors for whom treatment with Rozlytrek may be appropriate.

FDA 123

FDA 123

pharmaphorum

JUNE 23, 2022

Around the world, women are making important contributions to life sciences. In this series, we chart the career progression of notable women across the industry to find out what drew them to study science and how we can encourage more women to consider a role in STEM. In this edition, Giulia Guerrini, the lead pharmacist for digital pharmacy medino, discusses her journey from classics student in Italy to start-up superintendent and why it’s important to champion women in leadership positions.

Labelling 95

Labelling 95

Pharmacy Times

JUNE 23, 2022

Simplifying processes reduces errors in compounding, IV pump programming, and physician order entry.

Compounding 123

Compounding 123

Fossil Remedies

JUNE 23, 2022

If you see the growth pattern of the Indian economy, then it has been tremendous. The country has done remarkably well and despite the setback after the pandemic, it is roaring high with full speed. All sector of the Indian economy has done good, but the pharma sector is doing exceptionally well. It is among the fastest-growing sectors in India. Since there is an opportunity to earn, every dynamic business owner wants to reap benefits from that.

91

91

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JUNE 23, 2022

This year's theme "Team Up!" encourages pharmacists and their teams to meet in-person at the NCPA Annual Convention.

123

123

Pharmaceutical Technology

JUNE 23, 2022

In the last year, well-known contract manufacturing organisations (CMOs) such as Agilent Technologies (Santa Clara, California) and Abzena (Cambridge, UK) have expanded their continuous manufacturing capabilities. US Congress is also making substantial investments to improve the continuous manufacturing of pharmaceuticals. As more drugs are approved with continuous manufacturing, this production method is becoming increasingly mainstream.

FDA 64

FDA 64

Pharmacy Times

JUNE 23, 2022

There is a need to stop health disparities in our public health communities, especially in the LGBTQ+ space.

122

122

Pharmaceutical Technology

JUNE 23, 2022

The US Food and Drug Administration (FDA) has granted approval for Merck's (MSD outside the US and Canada) pneumococcal 15-valent conjugate vaccine, Vaxneuvance, for use in children aged six weeks to 17 years. The vaccine is intended for active immunisation to prevent invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in people aged six weeks and above.

Vaccines 59

Vaccines FDA Research Laboratories Immunization 59

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JUNE 23, 2022

This month's OTC product news features contact lenses for astigmatism, supplements, and children's probiotics.

120

120

Pharmaceutical Technology

JUNE 23, 2022

As recent changes to the price setting of drugs have improved the market access risk environment in France, GlobalData looks at their impact on the pricing of orphan drugs. Changes to price negotiations positive for orphan drugs. The changes in question were introduced via the new contractual agreement signed by the French Pharmaceutical Companies Association (LEEM) and the Ministry of Health’s (MoH’s) Economic Committee for Health Products (CEPS) in March 2021.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

Pharmacy Times

JUNE 23, 2022

Arthriten may offer relief from minor arthritis pain.

65

65

Pharma Times

JUNE 23, 2022

The company has renewed its pledge to eliminate neglected tropical diseases and malaria over five years

55

55

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JUNE 23, 2022

Acuvail ophthalmic solution is a nonsteroidal, anti-inflammatory indicated for the treatment of pain and inflammation following cataract surgery.

65

65

Viseven

JUNE 23, 2022

The faster digitalization goes worldwide, the more pharma companies find out about new tools and approaches for digital self-promotion. Digitalization brought new challenges to any industry related to online activities and social influence. Pharma and the specialties of pharma’s marketing appeared to be under influence as well. Modern days marketers are as good as quickly they adapt and overcome today’s challenges.

Communication 52

Communication 52

Pharmacy Times

JUNE 23, 2022

In clinical trials, dabrafenib and trametinib showed meaningful efficacy in multiple BRAF-positive tumor types, including in patients with rare cancers who have no other treatment options available.

FDA 65

FDA 65

Outsourcing Pharma

JUNE 23, 2022

The trial financial management company outlined a range of solutions designed to help trial teams get a handle on budgeting, patient reimbursement, and more.

52

52

Pharmaceutical Technology

JUNE 23, 2022

The metaverse will make digital media experiences more immersive, inclusive, and accessible than today. However, it will raise social concerns ranging from data privacy to other forms of online harm. Listed below are the key regulatory trends impacting the metaverse theme, as identified by GlobalData. Net neutrality. Net neutrality refers to the concept that a telecom network should be a neutral gateway to the Internet rather than a gatekeeper with the power to decide what content is available o

52

52

PharmExec

JUNE 23, 2022

In episode 111, Kevin Ali, CEO of Organon, talks about how’s he’s lead the launch of a new niche company for women’s health, and what he hopes it can achieve.

52

52

Pharmaceutical Technology

JUNE 23, 2022

Researchers at the University of New Hampshire (UNH) have found that a repurposed drug, CCG-50014, could hinder the activity of a key enzyme of the SARS-CoV-2 virus, which causes Covid-19. Utilising a currently available drug compound in a new way is called drug repurposing. The main protease enzyme Mpro, a key enzyme related to Covid-19, was the key target of the team in the study.

Compounding 52

Compounding 52

Outsourcing Pharma

JUNE 23, 2022

The 32nd iteration of the companyâs Beyond Borders report offers an in-depth look at the state of the current market landscape, and whatâs on the horizon.

52

52

Pharmaceutical Technology

JUNE 23, 2022

Gaming and social media companies are at the vanguard of metaverse development, but enterprises will lead the charge in the next three years. This shift will be driven by the future of work and digital transformation initiatives ongoing across sectors ranging from retail to healthcare and financial services. Big Tech is championing the metaverse, with Microsoft and Meta promoting it as the ideal environment to support hybrid working.

52

52

pharmaphorum

JUNE 23, 2022

US biotech Enanta Pharma has filed a lawsuit against Pfizer, claiming that its oral antiviral for COVID-19 Paxlovid infringes one of its patents and seeking damages from the pharma giant. The suit – filed in a Massachusetts district court – claims that Paxlovid (nirmatrelvir and ritonavir) infringes its 11,358,953 patent which covers “compounds and pharmaceutically acceptable salts which inhibit coronavirus replication activity, and methods of treating a coronavirus infection” and wa

Compounding 52

Compounding Documentation FDA 52

Pharmaceutical Technology

JUNE 23, 2022

The proportion of pharmaceutical companies hiring for robotics related positions rose in May 2022 compared with the equivalent month last year, with 20.8% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 19.7% of companies who were hiring for robotics related jobs a year ago but a decrease compared to the figure of 21.8% in April 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 23, 2022

Novartis’ two-drug regimen of Tafinlar and Mekinist has been approved by the FDA as the first therapy for solid tumours that have a BRAF V600E mutation – regardless of where they occur in the body. The so-called “tumour-agnostic” indication for BRAF inhibitor Tafinlar (dabrafenib) and MEK inhibitor Mekinist (trametinib) covers patients aged six and over with tumours that have progressed after earlier treatment and have no alternative therapies available.

FDA 52

FDA Chemotherapy 52

Pharmaceutical Commerce

JUNE 23, 2022

CDMO looks to combat cancer at lower doses.

40

40

Pharmaceutical Technology

JUNE 23, 2022

The European Commission (EC) has approved Novartis’ Tabrecta (capmatinib) as a monotherapy to treat advanced non-small cell lung cancer (NSCLC) in adults. The treatment is intended for patients with NSCLC harbouring alterations leading to mesenchymal-epithelial-transition factor gene (MET) exon 14 (METex14) skipping and for those who need systemic therapy after previous treatment with immunotherapy and/or platinum-based chemotherapy.

Chemotherapy 105

Chemotherapy 105

Pharmacy Times

JUNE 23, 2022

Analysis shows that individuals who received treatment within 3 days of symptom onset with tixagevimab and cilgavimab reduced their risk by 88% compared with the placebo.

123

123